{"id":16051,"date":"2025-09-22T09:00:47","date_gmt":"2025-09-22T09:00:47","guid":{"rendered":"https:\/\/www.hiro-clinic.or.jp\/diet\/mounjaro-japan-approval-usage-en\/"},"modified":"2026-11-17T07:27:19","modified_gmt":"2026-11-17T07:27:19","slug":"mounjaro-japan-approval-usage-en","status":"publish","type":"post","link":"https:\/\/www.hiro-clinic.or.jp\/diet\/en\/mounjaro-japan-approval-usage\/","title":{"rendered":"Mounjaro&#8217;s approval status in Japan and how to use it correctly: a guide to the latest medical weight loss"},"content":{"rendered":"\n<div class=\"cv2-conclusion\"><p class=\"cv2-conclusion__t\"><span>Bottom line first<\/span>Short on time? Just read this<\/p><ul><li>In Japan, Mounjaro is approved as a treatment for type 2 diabetes; its use for treating obesity is currently limited to <strong>self-pay treatment<\/strong> not covered by health insurance<\/li><li>Mounjaro&#8217;s own international randomized controlled trials (the SURMOUNT trial series) have all shown <strong>substantial weight loss<\/strong><\/li><li>Mounjaro works best when <strong>combined with lifestyle improvements<\/strong> rather than used on its own<\/li><\/ul><\/div>\n\n\n\n<div class=\"what-you-learn-box\">\n<p><strong>What you&#8217;ll learn in this article<\/strong><\/p>\n<ul><li>Mounjaro&#8217;s approval status in Japan and where self-pay treatment fits in<\/li><li>The actual weight-loss figures shown in international clinical trials<\/li><li>Precautions to check when using it as self-pay treatment<\/li><li>The outlook for future approval and health insurance coverage<\/li><\/ul>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Introduction<\/strong><\/h2>\n\n<p class=\"wp-block-paragraph\"><strong>In Japan, Mounjaro is approved as a treatment for type 2 diabetes; its use for treating obesity is currently limited to self-pay treatment not covered by health insurance.<\/strong> In recent years, one drug drawing attention as a medical intervention for obesity and overweight is Mounjaro. Mounjaro is a dual agonist that acts as both a GLP-1 (glucagon-like peptide-1) receptor agonist and a GIP receptor agonist, and appetite-suppressing and weight-loss effects have been reported. This article explains Mounjaro&#8217;s approval status in Japan, the clinical evidence, indications for use and the outlook for the future.<\/p>\n\n<h2 class=\"wp-block-heading\"><strong>What is Mounjaro?<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Mounjaro is the world&#8217;s first dual agonist that acts simultaneously on the receptors for two incretin hormones, GIP and GLP-1.<\/strong> It was originally developed as a treatment for type 2 diabetes. GLP-1 is a hormone released from the digestive tract and is known to curb the rise in blood sugar after eating, promote a feeling of fullness and suppress appetite by slowing gastric emptying.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Applying these actions, it is sometimes used to support weight loss in patients with obesity or overweight. It is drawing attention in particular as one option when lifestyle improvements alone have not produced enough weight loss. However, results vary from person to person, and not everyone will get the same results.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Main mechanisms of action<\/strong><\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Appetite suppression: acts on the hypothalamus in the brain to increase the feeling of fullness.<br><\/li>\n\n\n<li>Slower gastric emptying: slows the digestion and absorption of food and curbs sharp rises in blood sugar after meals.<br><\/li>\n\n\n<li>Blood sugar improvement: promotes insulin secretion and helps improve glucose metabolism.<br><\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Approval status in Japan<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Currently, Mounjaro is officially approved in Japan only for the treatment of type 2 diabetes and has not been approved for the treatment of obesity disease.<\/strong> For this reason, when it is used for people with obesity disease, it is mainly provided as self-pay treatment (not covered by health insurance), and you pay the full cost yourself.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The key points of its approval status in Japan as of 2026 are as follows.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Status<\/th><\/tr><\/thead><tbody><tr><td>Approved for<\/td><td>Patients with type 2 diabetes<\/td><\/tr><tr><td>Form<\/td><td>Injection (given once weekly)<\/td><\/tr><tr><td>Health insurance coverage<\/td><td>Diabetes treatment only<\/td><\/tr><tr><td>Approval for obesity disease<\/td><td>None (mainly provided as self-pay treatment)<\/td><\/tr><tr><td>Cost<\/td><td>Full cost paid by the patient when used to treat obesity<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Overseas, the U.S. Food and Drug Administration (FDA) approved tirzepatide, the active ingredient of Mounjaro, as an obesity medication in 2023 (product name Zepbound), and significant weight loss has also been reported in international clinical trials [1]. Clinical research is also under way in Japan, and approval for obesity disease may be obtained in the future, but no clear timing for approval has been indicated at this point.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Clinical evidence for Mounjaro<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Weight-loss effect<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Mounjaro&#8217;s own international randomized controlled trials (the SURMOUNT trial series) have all shown substantial weight loss.<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>SURMOUNT-1 trial [2]: in 2,539 adults with obesity or overweight without type 2 diabetes who received the drug for 72 weeks, average weight loss of 20.9% in the highest-dose (15 mg) group, 19.5% in the 10 mg group and 15% in the 5 mg group was reported.<br><\/li>\n\n\n<li>SURMOUNT-2 trial [3]: in a trial of adults with obesity or overweight who also had type 2 diabetes, weight loss of more than 10% was confirmed depending on dose, along with improvement in HbA1c.<br><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">These trials showed that greater weight loss is achieved when combined with guidance on lifestyle improvement (diet and exercise). Note that all of the above are averages from clinical trials, and actual effects and the amount of weight lost vary from person to person. Please note that this does not guarantee that you will &#8220;definitely lose this much weight.&#8221;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Safety<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Mounjaro&#8217;s main side effects are gastrointestinal symptoms, and nausea, vomiting, diarrhea and constipation have been reported. In rare cases, risks of pancreatitis and gallbladder disease have also been noted. When it is used in Japan, careful monitoring by a doctor is required, with reference to clinical data from overseas.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Possibility of use in Japan<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Although Mounjaro is not officially approved for the treatment of obesity disease, there are cases where it is used under the following conditions.<\/strong><\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Introduction as self-pay treatment <br>Some clinics in Japan offer Mounjaro as self-pay treatment for the purpose of treating obesity, based on its approval for diabetes treatment. In this case, the doctor decides the dose, dosing interval and so on with reference to overseas guidelines and clinical research.<br><\/li>\n\n\n<li>Participation in clinical trials or clinical research <br>Clinical trials of Mounjaro for obesity disease are also under way in Japan, and in some cases you may be able to use it by taking part in research.<br><\/li>\n\n\n<li>Use of overseas approval data <br>There are moves to build up evidence for introduction in Japan based on the FDA-approved obesity treatment data. Collecting safety and efficacy data in Japanese people in particular will be key to obtaining approval in the future.<br><\/li>\n<\/ol>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"427\" src=\"https:\/\/www.hiro-clinic.or.jp\/diet\/wp-content\/uploads\/2025\/09\/28973471_s.webp\" alt=\"Image of a person who succeeded in losing weight\" class=\"wp-image-1127\" srcset=\"https:\/\/www.hiro-clinic.or.jp\/diet\/wp-content\/uploads\/2025\/09\/28973471_s.webp 640w, https:\/\/www.hiro-clinic.or.jp\/diet\/wp-content\/uploads\/2025\/09\/28973471_s-300x200.webp 300w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/figure>\n<\/div>\n\n\n  <a href=\"https:\/\/www.hiro-clinic.or.jp\/diet\/mounjaro-eiyou-seikatsu-kanri\/\" class=\"blogcard\">\n    <div class=\"blogcard-content\">\n      <h3 class=\"blogcard-title\">\n        \u30de\u30f3\u30b8\u30e3\u30ed\u4f7f\u7528\u4e2d\u306e\u6804\u990a\u7ba1\u7406\u3068\u751f\u6d3b\u7fd2\u6163\uff5c\u52b9\u679c\u3092\u6700\u5927\u5316\u3057\u30ea\u30d0\u30a6\u30f3\u30c9\u3092\u9632\u3050\u30b3\u30c4\u3092\u533b\u5e2b\u304c\u89e3\u8aac      <\/h3>\n      <small class=\"blogcard-excerpt\">\n        \u5148\u306b\u7d50\u8ad6\u5fd9\u3057\u3044\u65b9\u306f\u3053\u3053\u3060\u3051\u8aad\u3081\u3070OK\u30de\u30f3\u30b8\u30e3\u30ed\u306e\u52b9\u679c\u3092\u9577\u671f\u7684\u306b\u7dad\u6301\u3057\u30ea\u30d0\u30a6\u30f3\u30c9...\t  <\/small>\n    <\/div>\n  <\/a>\n\n  \n\n\n\n  <a href=\"https:\/\/www.hiro-clinic.or.jp\/diet\/manjaro-fukusayou-anzen\/\" class=\"blogcard\">\n    <div class=\"blogcard-content\">\n      <h3 class=\"blogcard-title\">\n        \u30de\u30f3\u30b8\u30e3\u30ed\u306e\u526f\u4f5c\u7528\uff5c\u7a2e\u985e\u30fb\u983b\u5ea6\u30fb\u5bfe\u51e6\u6cd5\u3092\u533b\u5e2b\u304c\u89e3\u8aac      <\/h3>\n      <small class=\"blogcard-excerpt\">\n        \u5148\u306b\u7d50\u8ad6\u5fd9\u3057\u3044\u65b9\u306f\u3053\u3053\u3060\u3051\u8aad\u3081\u3070OK \u30de\u30f3\u30b8\u30e3\u30ed\u306e\u526f\u4f5c\u7528\u306f\u5410\u304d\u6c17\u30fb\u4e0b\u75e2\u30fb\u4fbf\u79d8\u306a\u3069...\t  <\/small>\n    <\/div>\n  <\/a>\n\n  \n\n\n\n<h2 class=\"wp-block-heading\"><strong>Future outlook<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Approval of Mounjaro for the treatment of obesity disease in Japan becomes more likely as Japanese data accumulate and are reflected in guidelines.<\/strong><\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Accumulation of Japanese clinical data <br>Once enough safety and efficacy data in Japanese people are obtained, approval review by the Ministry of Health, Labour and Welfare will move forward.<br><\/li>\n\n\n<li>Inclusion in obesity treatment guidelines <br>If specialist societies such as the Japan Society for the Study of Obesity include it in their guidance for use, awareness in clinical practice will increase.<br><\/li>\n\n\n<li>Possibility of health insurance coverage <br>If approval for the treatment of obesity disease is obtained in the future, a shift from self-pay treatment to insurance-covered care may become possible, allowing it to be used at lower financial burden.<br><\/li>\n\n\n<li>Comprehensive treatment through multidisciplinary collaboration <br>Collaboration among doctors, registered dietitians, exercise therapists and others makes it possible to achieve sustained weight management that the drug alone cannot provide.<br><\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Precautions for use<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>When using Mounjaro, please keep the following points in mind.<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Managing gastrointestinal symptoms: because nausea and vomiting tend to occur when starting treatment, the dose is increased gradually (&#8220;stepwise dose escalation&#8221;).<br><\/li>\n\n\n<li>Interactions with other medications: caution is needed especially when used together with oral diabetes medications or anticoagulants.<br><\/li>\n\n\n<li>Checking medical history: people with pancreatitis, gallstones or kidney problems need to use it with caution.<br><\/li>\n\n\n<li>No use on your own judgment: even as self-pay treatment, it must be used under a doctor&#8217;s supervision. Please avoid obtaining it through personal import or using it on your own judgment.<br><\/li>\n<\/ul>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-fe48e5de wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-fill\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.hiro-clinic.or.jp\/diet\/price\/\">See Mounjaro prices and self-pay treatment details<\/a><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-fe48e5de wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-outline is-style-outline--1\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.hiro-clinic.or.jp\/diet\/line\/\">Get a free consultation on our official LINE account<\/a><\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>The significance of Mounjaro from a healthcare professional&#8217;s perspective<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>For healthcare professionals, Mounjaro is a new option for people who have had difficulty getting results with conventional weight-loss support.<\/strong> In our practice, we sometimes hear from people who say &#8220;I couldn&#8217;t keep up treatment at another clinic,&#8221; and we feel that having more options is meaningful in itself. In counseling, we are also often asked about the cost and the fact that it is self-pay treatment, and each time we make a point of carefully explaining that it is not covered by health insurance and that results vary from person to person. The following points in particular are drawing attention.<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Safety evaluation premised on medication management <br>Clinical data from overseas are advancing the evaluation of cardiovascular risk and effects on improving glucose metabolism.<br><\/li>\n\n\n<li>Diverse applications in clinical practice <br>It may help reduce the risk not only for patients with diabetes but also of lifestyle-related diseases associated with obesity, such as dyslipidemia and high blood pressure.<br><\/li>\n\n\n<li>Greater patient motivation <br>In some cases, the visible change of weight loss leads to more motivation to improve lifestyle habits.<br><\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Research trends<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Research on Mounjaro is also actively under way in Japan.<\/strong> The following themes in particular are drawing attention.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Verifying the weight-loss effect in Japanese people <br>Because of differences in physique and eating habits, data from overseas trials may not apply directly in Japan, so verification of the effect in Japanese people is needed.<br><\/li>\n\n\n<li>Evaluating long-term safety <br>The incidence of gastrointestinal symptoms, pancreatitis, gallstones and so on during use over several years is being tracked, building up safety data toward approval in Japan.<br><\/li>\n\n\n<li>Confirming cardiovascular risk reduction <br>Research is also under way to verify whether weight loss helps prevent cardiovascular disease, which would be an indicator that raises the social significance of obesity treatment.<br><\/li>\n<\/ul>\n\n\n\n  <a href=\"https:\/\/www.hiro-clinic.or.jp\/diet\/manjaro-glp1-sakyou-sa\/\" class=\"blogcard\">\n    <div class=\"blogcard-content\">\n      <h3 class=\"blogcard-title\">\n        \u30de\u30f3\u30b8\u30e3\u30ed\u306e\u4f5c\u7528\u6a5f\u5e8f\uff5cGIP\u3068GLP-1\u306e2\u3064\u306b\u52b9\u304f\u4ed5\u7d44\u307f\u3092\u533b\u5e2b\u304c\u89e3\u8aac      <\/h3>\n      <small class=\"blogcard-excerpt\">\n        \u30de\u30f3\u30b8\u30e3\u30ed\u306f\u3001GIP\u3068GLP-1\u3068\u3044\u30462\u7a2e\u985e\u306e\u30db\u30eb\u30e2\u30f3\u306b\u540c\u6642\u306b\u4f5c\u7528\u3059\u308b\u70b9\u3067\u3001\u65e2\u5b58\u306eGLP-...\t  <\/small>\n    <\/div>\n  <\/a>\n\n  \n\n\n\n  <a href=\"https:\/\/www.hiro-clinic.or.jp\/diet\/manjaro-genryou-clinical-data\/\" class=\"blogcard\">\n    <div class=\"blogcard-content\">\n      <h3 class=\"blogcard-title\">\n        \u30de\u30f3\u30b8\u30e3\u30ed\u306e\u81e8\u5e8a\u30c7\u30fc\u30bf\u3068\u6e1b\u91cf\u52b9\u679c\uff5c\u533b\u5b66\u7684\u6839\u62e0\u306b\u57fa\u3065\u304f\u6700\u65b0\u306e\u30c0\u30a4\u30a8\u30c3\u30c8\u5b9f\u7e3e\u3092\u89e3\u8aac      <\/h3>\n      <small class=\"blogcard-excerpt\">\n        \u5148\u306b\u7d50\u8ad6\u5fd9\u3057\u3044\u65b9\u306f\u3053\u3053\u3060\u3051\u8aad\u3081\u3070OK \u30de\u30f3\u30b8\u30e3\u30ed\u306f\u3001\u8907\u6570\u306e\u5927\u898f\u6a21\u81e8\u5e8a\u8a66\u9a13\u306b\u3088\u3063\u3066...\t  <\/small>\n    <\/div>\n  <\/a>\n\n  \n\n\n\n<h2 class=\"wp-block-heading\"><strong>Combining it with lifestyle management at home<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Mounjaro works best when combined with lifestyle improvements rather than used on its own.<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Diet management <br>Aim for nutritionally balanced meals, and in particular adjust how much carbohydrate and fat you eat.<br><\/li>\n\n\n<li>Exercise therapy <br>Combining aerobic exercise and strength training helps maintain basal metabolism and supports fat burning.<br><\/li>\n\n\n<li>Behavior change support <br>Recording your weight, meals and exercise in a diary or app and improving your self-management skills helps you maintain weight loss over the long term.<br><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">On X (formerly Twitter), too, there are posts from users of Mounjaro reporting lifestyle adjustments such as &#8220;I started strength training for my legs and abdomen while getting enough protein.&#8221; These are only personal records and do not guarantee results, but the attitude of improving lifestyle habits instead of relying on the drug alone matches the points doctors also recommend.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">\u3088\u304f\u3042\u308b\u8cea\u554f(FAQ)<\/h2>\n\n\n\n<div class=\"cv2-faqs\"><details class=\"cv2-faq\" open><summary><span class=\"cv2-q\">Q<\/span>Can I get Mounjaro prescribed in Japan for weight loss?<\/summary><div class=\"cv2-a\"><span class=\"cv2-aa\">A<\/span><div><p>It has not yet been approved for the treatment of obesity disease itself, but you may be able to get a prescription at medical facilities that offer it as self-pay treatment. Please consider it with the understanding that health insurance does not apply and you pay the full cost yourself.<\/p><\/div><\/div><\/details><details class=\"cv2-faq\" open><summary><span class=\"cv2-q\">Q<\/span>Is it okay to buy Mounjaro through personal import?<\/summary><div class=\"cv2-a\"><span class=\"cv2-aa\">A<\/span><div><p>We do not recommend personal import because quality and safety cannot be confirmed. There is a risk of counterfeit products and a risk of not being under a doctor&#8217;s supervision, so always get a prescription through a medical facility.<\/p><\/div><\/div><\/details><details class=\"cv2-faq\" open><summary><span class=\"cv2-q\">Q<\/span>Will Mounjaro be covered by health insurance in the future?<\/summary><div class=\"cv2-a\"><span class=\"cv2-aa\">A<\/span><div><p>If approval for the treatment of obesity disease is obtained in Japan, a shift to insurance-covered care may become possible. However, no specific timing for approval has been indicated at this point, and it is expected to continue to be provided as self-pay treatment for the time being.<\/p><\/div><\/div><\/details><details class=\"cv2-faq\" open><summary><span class=\"cv2-q\">Q<\/span>Do overseas clinical trial data apply directly to Japanese people?<\/summary><div class=\"cv2-a\"><span class=\"cv2-aa\">A<\/span><div><p>Because of differences in physique and eating habits, overseas data do not necessarily apply directly. Verification of efficacy and safety in Japanese people is still continuing.<\/p><\/div><\/div><\/details><details class=\"cv2-faq\" open><summary><span class=\"cv2-q\">Q<\/span>Can I use Mounjaro if I don&#8217;t have diabetes?<\/summary><div class=\"cv2-a\"><span class=\"cv2-aa\">A<\/span><div><p>Approval in Japan is limited to the treatment of type 2 diabetes, but self-pay clinics also prescribe it to people without diabetes. Whether you can use it is decided by a doctor&#8217;s examination and assessment.<\/p><\/div><\/div><\/details><\/div>\n\n\n\n<script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@type\": \"FAQPage\",\n  \"mainEntity\": [\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Can I get Mounjaro prescribed in Japan for weight loss?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"It has not yet been approved for the treatment of obesity disease itself, but you may be able to get a prescription at medical facilities that offer it as self-pay treatment. Please consider it with the understanding that health insurance does not apply and you pay the full cost yourself.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Is it okay to buy Mounjaro through personal import?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"We do not recommend personal import because quality and safety cannot be confirmed. There is a risk of counterfeit products and a risk of not being under a doctor's supervision, so always get a prescription through a medical facility.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Will Mounjaro be covered by health insurance in the future?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"If approval for the treatment of obesity disease is obtained in Japan, a shift to insurance-covered care may become possible. However, no specific timing for approval has been indicated at this point, and it is expected to continue to be provided as self-pay treatment for the time being.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Do overseas clinical trial data apply directly to Japanese people?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Because of differences in physique and eating habits, overseas data do not necessarily apply directly. Verification of efficacy and safety in Japanese people is still continuing.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Can I use Mounjaro if I don't have diabetes?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Approval in Japan is limited to the treatment of type 2 diabetes, but self-pay clinics also prescribe it to people without diabetes. Whether you can use it is decided by a doctor's examination and assessment.\"\n      }\n    }\n  ]\n}\n<\/script>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Summary<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Mounjaro is a drug that can be one option in the treatment of obesity disease.<\/strong> In Japan, it is currently approved only for diabetes treatment, but given its track record in treating obesity disease overseas and the progress of clinical research in Japan, future approval and wider use are anticipated.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">What matters for patients is not to use Mounjaro on its own, but to combine it with lifestyle improvements under a doctor&#8217;s supervision, and to consider treatment with a correct understanding that it is self-pay treatment and of the costs involved. For healthcare professionals, too, further data are anticipated as it offers a new option for patients who do not get enough results from conventional weight-loss methods.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-fe48e5de wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-fill\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.hiro-clinic.or.jp\/diet\/faq\/\">See the frequently asked questions page<\/a><\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>References<\/strong><\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li>FDA. <em>FDA Approves New Medication for Chronic Weight Management.<\/em> 2023.<br><a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-medication-chronic-weight-management\" target=\"_blank\" rel=\"noopener nofollow\">See the official FDA announcement<\/a><br><\/li>\n\n\n<li>Jastreboff AM, et al. <em>Tirzepatide Once Weekly for the Treatment of Obesity.<\/em> N Engl J Med. 2022;387:205-216. (SURMOUNT-1 trial)<br><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2206038\" target=\"_blank\" rel=\"noopener nofollow\">Read the original paper (NEJM)<\/a><br><\/li>\n\n\n<li>Garvey WT, et al. <em>Tirzepatide for weight reduction in patients with type 2 diabetes.<\/em> Lancet. 2023;402:613-626. (SURMOUNT-2 trial)<br><a href=\"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(23)01200-X\/fulltext\" target=\"_blank\" rel=\"noopener nofollow\">Read the original paper (The Lancet)<\/a><br><\/li>\n\n\n<li>American Diabetes Association. <em>Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes\u20142025.<\/em> Diabetes Care. 2025;48(Suppl. 1):S123-S141.<br><a href=\"https:\/\/diabetesjournals.org\/care\/article\/48\/Supplement_1\/S123\/155514\/\" target=\"_blank\" rel=\"noopener nofollow\">Read the original paper (Diabetes Care)<\/a><br><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\" style=\"font-size:0.85em;color:#666;\">Medically reviewed by: Dr. Hiroko Oka (Chair, Fukubikai Medical Corporation \/ Certified Member, Japanese Society of Internal Medicine)<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"mounjaro-safety-contact\">Who to contact if you have side effects | When to see a doctor<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>If you have any of the following symptoms, please contact us rather than waiting to see on your own judgment.<\/strong> GIP\/GLP-1 receptor agonists, including Mounjaro, are known to cause side effects, mainly gastrointestinal symptoms. Most are mild, but in rare cases they can be serious.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><thead><tr><th>Symptoms<\/th><th>Possible cause<\/th><th>What to do<\/th><\/tr><\/thead><tbody>\n<tr><td>Continuing nausea or vomiting<\/td><td>Gastrointestinal symptoms. The most common side effect<\/td><td>Please contact us if you remain unable to keep fluids down<\/td><\/tr>\n<tr class=\"is-urgent\"><td><strong>Severe abdominal pain<\/strong> (pain radiating to the back)<\/td><td><strong>Possible acute pancreatitis<\/strong><\/td><td>Stop the medication immediately and see a doctor<\/td><\/tr>\n<tr><td>Cold sweats, palpitations, intense hunger, feeling confused or drowsy<\/td><td><strong>Hypoglycemia<\/strong><\/td><td>Take sugar right away and contact us<\/td><\/tr>\n<tr class=\"is-urgent\"><td>Skin rash, difficulty breathing, swelling of the face or throat<\/td><td>Allergic reaction<\/td><td>See a doctor immediately<\/td><\/tr>\n<\/tbody><\/table><\/figure>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><strong>Contact: <a href=\"tel:0120241929\">0120-241-929<\/a> (hours 9:00\u201318:00)<\/strong><br>If your symptoms are severe outside these hours, please go to your nearest emergency medical facility.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Direct phone numbers for each clinic are listed on the <a href=\"\/diet\/clinic-info\/\">clinic information<\/a> page.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">References<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The information on medications in this article is based on the following official sources. For details on dosage and administration and side effects, always check the latest electronic package insert.<br>\n<a href=\"https:\/\/www.pmda.go.jp\/PmdaSearch\/rdDetail\/iyaku\/2499422G1024_1\" target=\"_blank\" rel=\"noopener\">Pharmaceuticals and Medical Devices Agency (PMDA): &#8220;Mounjaro Subcutaneous Injection Ateos, electronic package insert&#8221; (Japanese)<\/a><br>\n<a href=\"https:\/\/www.info.pmda.go.jp\/downfiles\/guide\/ph\/530471_2499422G1024_1_00G.pdf\" target=\"_blank\" rel=\"noopener\">PMDA: &#8220;Drug Guide for Patients: Mounjaro Subcutaneous Injection Ateos&#8221; (PDF, Japanese)<\/a><br>\n<a href=\"https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/kenkou_iryou\/kenkou\/seikatsu\/index.html\" target=\"_blank\" rel=\"noopener\">Ministry of Health, Labour and Welfare: &#8220;Prevention of lifestyle-related diseases&#8221; (Japanese)<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>When Mounjaro is used for purposes other than obesity disease, it is self-pay treatment and public health insurance does not apply. Effects and side effects vary from person to person.<\/em><\/p>\n\n","protected":false},"excerpt":{"rendered":"<p>Bottom line firstShort on time? Just read this In Japan, Mounjaro is approved as a treatment for type 2 diabet [&hellip;]<\/p>\n","protected":false},"author":49,"featured_media":1139,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[171],"tags":[37,14,172,157],"class_list":["post-16051","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-171","tag-37","tag-14","tag-172","tag-157"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mounjaro in Japan: approval status and use | Medical weight loss<\/title>\n<meta name=\"description\" content=\"A specialist explains Mounjaro&#039;s approval status in Japan, how it works as a GIP\/GLP-1 receptor agonist, self-pay use for weight loss, side effects and precautions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hiro-clinic.or.jp\/diet\/en\/mounjaro-japan-approval-usage\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mounjaro in Japan: approval status and use | Medical weight loss\" \/>\n<meta property=\"og:description\" content=\"A specialist explains Mounjaro&#039;s approval status in Japan, how it works as a GIP\/GLP-1 receptor agonist, self-pay use for weight loss, side effects and precautions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hiro-clinic.or.jp\/diet\/en\/mounjaro-japan-approval-usage\/\" \/>\n<meta property=\"og:site_name\" content=\"\u30d2\u30ed\u30af\u30ea\u30cb\u30c3\u30af\u533b\u7642\u30c0\u30a4\u30a8\u30c3\u30c8\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-22T09:00:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-17T07:27:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hiro-clinic.or.jp\/diet\/wp-content\/uploads\/2025\/09\/31388124_s.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"427\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"fujitanaoki\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"fujitanaoki\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"12\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mounjaro in Japan: approval status and use | Medical weight loss","description":"A specialist explains Mounjaro's approval status in Japan, how it works as a GIP\/GLP-1 receptor agonist, self-pay use for weight loss, side effects and precautions.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hiro-clinic.or.jp\/diet\/en\/mounjaro-japan-approval-usage\/","og_locale":"ja_JP","og_type":"article","og_title":"Mounjaro in Japan: approval status and use | Medical weight loss","og_description":"A specialist explains Mounjaro's approval status in Japan, how it works as a GIP\/GLP-1 receptor agonist, self-pay use for weight loss, side effects and precautions.","og_url":"https:\/\/www.hiro-clinic.or.jp\/diet\/en\/mounjaro-japan-approval-usage\/","og_site_name":"\u30d2\u30ed\u30af\u30ea\u30cb\u30c3\u30af\u533b\u7642\u30c0\u30a4\u30a8\u30c3\u30c8","article_published_time":"2025-09-22T09:00:47+00:00","article_modified_time":"2026-11-17T07:27:19+00:00","og_image":[{"width":640,"height":427,"url":"https:\/\/www.hiro-clinic.or.jp\/diet\/wp-content\/uploads\/2025\/09\/31388124_s.webp","type":"image\/webp"}],"author":"fujitanaoki","twitter_card":"summary_large_image","twitter_misc":{"Written by":"fujitanaoki","Est. reading time":"12\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hiro-clinic.or.jp\/diet\/en\/mounjaro-japan-approval-usage\/#article","isPartOf":{"@id":"https:\/\/www.hiro-clinic.or.jp\/diet\/en\/mounjaro-japan-approval-usage\/"},"author":{"name":"fujitanaoki","@id":"https:\/\/www.hiro-clinic.or.jp\/diet\/#\/schema\/person\/a28fded3d78d5f9df507e158668eb48f"},"headline":"Mounjaro&#8217;s approval status in Japan and how to use it correctly: a guide to the latest medical weight loss","datePublished":"2025-09-22T09:00:47+00:00","dateModified":"2026-11-17T07:27:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hiro-clinic.or.jp\/diet\/en\/mounjaro-japan-approval-usage\/"},"wordCount":2406,"commentCount":0,"image":{"@id":"https:\/\/www.hiro-clinic.or.jp\/diet\/en\/mounjaro-japan-approval-usage\/#primaryimage"},"thumbnailUrl":"https:\/\/www.hiro-clinic.or.jp\/diet\/wp-content\/uploads\/2025\/09\/31388124_s.webp","keywords":["\u30c0\u30a4\u30a8\u30c3\u30c8","\u30de\u30f3\u30b8\u30e3\u30ed","\u30de\u30f3\u30b8\u30e3\u30ed\u6ce8\u5c04","\u533b\u7642\u30c0\u30a4\u30a8\u30c3\u30c8"],"articleSection":["\u30de\u30f3\u30b8\u30e3\u30ed\u6ce8\u5c04"],"inLanguage":"ja","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.hiro-clinic.or.jp\/diet\/en\/mounjaro-japan-approval-usage\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.hiro-clinic.or.jp\/diet\/en\/mounjaro-japan-approval-usage\/","url":"https:\/\/www.hiro-clinic.or.jp\/diet\/en\/mounjaro-japan-approval-usage\/","name":"Mounjaro in Japan: approval status and use | Medical weight loss","isPartOf":{"@id":"https:\/\/www.hiro-clinic.or.jp\/diet\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.hiro-clinic.or.jp\/diet\/en\/mounjaro-japan-approval-usage\/#primaryimage"},"image":{"@id":"https:\/\/www.hiro-clinic.or.jp\/diet\/en\/mounjaro-japan-approval-usage\/#primaryimage"},"thumbnailUrl":"https:\/\/www.hiro-clinic.or.jp\/diet\/wp-content\/uploads\/2025\/09\/31388124_s.webp","datePublished":"2025-09-22T09:00:47+00:00","dateModified":"2026-11-17T07:27:19+00:00","author":{"@id":"https:\/\/www.hiro-clinic.or.jp\/diet\/#\/schema\/person\/a28fded3d78d5f9df507e158668eb48f"},"description":"A specialist explains Mounjaro's approval status in Japan, how it works as a GIP\/GLP-1 receptor agonist, self-pay use for weight loss, side effects and precautions.","breadcrumb":{"@id":"https:\/\/www.hiro-clinic.or.jp\/diet\/en\/mounjaro-japan-approval-usage\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hiro-clinic.or.jp\/diet\/en\/mounjaro-japan-approval-usage\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.hiro-clinic.or.jp\/diet\/en\/mounjaro-japan-approval-usage\/#primaryimage","url":"https:\/\/www.hiro-clinic.or.jp\/diet\/wp-content\/uploads\/2025\/09\/31388124_s.webp","contentUrl":"https:\/\/www.hiro-clinic.or.jp\/diet\/wp-content\/uploads\/2025\/09\/31388124_s.webp","width":640,"height":427,"caption":"\u533b\u8005"},{"@type":"BreadcrumbList","@id":"https:\/\/www.hiro-clinic.or.jp\/diet\/en\/mounjaro-japan-approval-usage\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.hiro-clinic.or.jp\/diet\/"},{"@type":"ListItem","position":2,"name":"Mounjaro&#8217;s approval status in Japan and how to use it correctly: a guide to the latest medical weight loss"}]},{"@type":"WebSite","@id":"https:\/\/www.hiro-clinic.or.jp\/diet\/#website","url":"https:\/\/www.hiro-clinic.or.jp\/diet\/","name":"\u30d2\u30ed\u30af\u30ea\u30cb\u30c3\u30af\u533b\u7642\u30c0\u30a4\u30a8\u30c3\u30c8","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hiro-clinic.or.jp\/diet\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Person","@id":"https:\/\/www.hiro-clinic.or.jp\/diet\/#\/schema\/person\/a28fded3d78d5f9df507e158668eb48f","name":"fujitanaoki","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/secure.gravatar.com\/avatar\/76192f07e3cf18f67455110082d9b0fc56c218fb3f582c3a8de3817cb7059af9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/76192f07e3cf18f67455110082d9b0fc56c218fb3f582c3a8de3817cb7059af9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/76192f07e3cf18f67455110082d9b0fc56c218fb3f582c3a8de3817cb7059af9?s=96&d=mm&r=g","caption":"fujitanaoki"},"url":"https:\/\/www.hiro-clinic.or.jp\/diet\/author\/fujitanaoki\/"}]}},"_links":{"self":[{"href":"https:\/\/www.hiro-clinic.or.jp\/diet\/wp-json\/wp\/v2\/posts\/16051","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hiro-clinic.or.jp\/diet\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hiro-clinic.or.jp\/diet\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hiro-clinic.or.jp\/diet\/wp-json\/wp\/v2\/users\/49"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hiro-clinic.or.jp\/diet\/wp-json\/wp\/v2\/comments?post=16051"}],"version-history":[{"count":1,"href":"https:\/\/www.hiro-clinic.or.jp\/diet\/wp-json\/wp\/v2\/posts\/16051\/revisions"}],"predecessor-version":[{"id":17101,"href":"https:\/\/www.hiro-clinic.or.jp\/diet\/wp-json\/wp\/v2\/posts\/16051\/revisions\/17101"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.hiro-clinic.or.jp\/diet\/wp-json\/wp\/v2\/media\/1139"}],"wp:attachment":[{"href":"https:\/\/www.hiro-clinic.or.jp\/diet\/wp-json\/wp\/v2\/media?parent=16051"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hiro-clinic.or.jp\/diet\/wp-json\/wp\/v2\/categories?post=16051"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hiro-clinic.or.jp\/diet\/wp-json\/wp\/v2\/tags?post=16051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}